(2S)-2-[[4-[[(19S)-19-[4-[[(1S)-1-carboxy-3-methylbutyl]amino]-4-oxobutanoyl]oxy-10,19-diethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl]oxy]-4-oxobutanoyl]amino]-4-methylpentanoic acid

• 分子结构分类: 有机化合物 - 生物碱及其衍生物 - 喜树碱
• 英文名称: (2S)-2-[[4-[[(19S)-19-[4-[[(1S)-1-carboxy-3-methylbutyl]amino]-4-oxobutanoyl]oxy-10,19-diethyl-14,18-dioxo-17-oxa-3,13-diazapentacyclo[11.8.0.02,11.04,9.015,20]henicosa-1(21),2,4(9),5,7,10,15(20)-heptaen-7-yl]oxy]-4-oxobutanoyl]amino]-4-methylpentanoic acid
• 化学式: C₄₂H₅₀N₄O₁₃
• 分子量: 818.9
• InChiKey: ZMWGMDSQCJMKKH-YRYPVNBZSA-N

计算性质

• 辛醇/水分配系数(LogP)：
  3.1
• 重原子数：
  59
• 可旋转键数：
  20
• 环数：
  5.0
• sp3杂化的碳原子比例：
  0.5
• 拓扑面积：
  245
• 氢给体数：
  4
• 氢受体数：
  14

文献信息

• [EN] SOLUBLE COMPLEXES OF DRUG ANALOGS AND ALBUMIN<br/>[FR] COMPLEXES SOLUBLES D'ANALOGUES DE MÉDICAMENT ET D'ALBUMINE
  申请人：FL THERAPEUTICS LLC

  公开号：WO2014121033A1

  公开（公告）日：2014-08-07

  The present invention provides novel, non-covalently bound complexes of serum albumin and analogs of poorly soluble drugs, such as camptothecin. The novel complexes are significantly more water-soluble than the camptothecin analogs and are useful as prodrug forms of the camptothecin analogs for the treatment of mammalian cell proliferative diseases, such as cancer.

  本发明提供了血清白蛋白与溶解度较差药物的类似物（如喜树碱）的新型非共价结合复合物。这些新型复合物比喜树碱类似物更易溶于水，并可用作喜树碱类似物的前药形式，用于治疗哺乳动物细胞增殖性疾病，如癌症。
• SOLUBLE COMPLEXES OF DRUG ANALOGS AND ALBUMIN
  申请人：SUN Qun

  公开号：US20150366984A1

  公开（公告）日：2015-12-24

  The present invention provides novel, non-covalently bound complexes of serum albumin and analogs of poorly soluble drugs, such as camptothecin. The novel complexes are significantly more water-soluble than the camptothecin analogs and are useful as prodrug forms of the camptothecin analogs for the treatment of mammalian cell proliferative diseases, such as cancer.
• US9962452B2
  申请人：——

  公开号：US9962452B2

  公开（公告）日：2018-05-08